Last reviewed · How we verify
Bupivacaine Hydrochloride And Epinephrine (Bupivacaine Hydrochloride)
Bupivacaine Hydrochloride And Epinephrine (generic name: Bupivacaine Hydrochloride) is a Amide Local Anesthetic Small molecule drug developed by Pfizer. It is currently FDA-approved (first approved 1972) for Anesthesia for cesarean section, Itching of skin, Local Anesthesia for Ophthalmologic Procedure.
Bupivacaine Hydrochloride blocks nerve impulses by inhibiting sodium channels.
Bupivacaine Hydrochloride And Epinephrine (Bupivacaine Hydrochloride) is a local anesthetic drug developed by HOSPIRA and currently owned by Hospira. It works by targeting the cytochrome P450 2D6 enzyme and inhibiting sodium channels to block nerve impulses, providing pain relief. This medication is approved for various indications, including anesthesia for cesarean section, local anesthesia, and regional anesthesia for labor pain. Bupivacaine Hydrochloride is an off-patent, generic medication with 13 available manufacturers. Key safety considerations include its potential for toxicity and the need for careful dosing.
At a glance
| Generic name | Bupivacaine Hydrochloride |
|---|---|
| Sponsor | Pfizer |
| Drug class | Amide Local Anesthetic |
| Target | Cytochrome P450 2D6 |
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1972 |
Mechanism of action
Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. In general, the progression of anesthesia is related to the diameter, myelination, and conduction velocity of affected nerve fibers. Clinically, the order of loss of nerve function is as follows: (1) pain, (2) temperature, (3) touch, (4) proprioception, and (5) skeletal muscle tone.Epinephrine is vasoconstrictor added to bupivacaine to slow absorption into the general circulation and thus prolong maintenance of an active tissue concentration.
Approved indications
- Anesthesia for cesarean section
- Itching of skin
- Local Anesthesia for Ophthalmologic Procedure
- Local anesthesia
- Local anesthetic intrathecal block
- Major Nerve Block for Surgery
- Minor Skin Wound Pain
- Regional Anesthesia for Labor Pain
- Regional Anesthesia for Ophthalmologic Surgery
- Regional Anesthesia for Postoperative Pain
- Regional Anesthesia for Surgery
- Skin irritation
Boxed warnings
- WARNING: RISK OF CARDIAC ARREST WITH USE OF BUPIVACAINE HYDROCHLORIDE INJECTION IN OBSTETRICAL ANESTHESIA There have been reports of cardiac arrest with difficult resuscitation or death during use of Bupivacaine Hydrochloride Injection for epidural anesthesia in obstetrical patients. In most cases, this has followed use of the 0.75% (7.5 mg/mL) concentration. Resuscitation has been difficult or impossible despite apparently adequate preparation and appropriate management. Cardiac arrest has occurred after convulsions resulting from systemic toxicity, presumably following unintentional intravascular injection. The 0.75% (7.5 mg/mL) concentration of Bupivacaine Hydrochloride Injection is not recommended for obstetrical anesthesia and should be reserved for surgical procedures where a high degree of muscle relaxation and prolonged effect are necessary [see Warnings and Precautions (5.1) ]. WARNING: RISK OF CARDIAC ARREST WITH USE OF BUPIVACAINE HYDROCHLORIDE INJECTION IN OBSTETRICAL ANESTHESIA See full prescribing information for complete boxed warning. There have been reports of cardiac arrest with difficult resuscitation or death during use of Bupivacaine Hydrochloride Injection for epidural anesthesia in obstetrical patients. In most cases, this has followed use of the 0.75% (7.5 mg/mL) concentration. Resuscitation has been difficult or impossible despite apparently adequate preparation and appropriate management. Cardiac arrest has occurred after convulsions resulting from systemic toxicity, presumably following unintentional intravascular injection. The 0.75% (7.5 mg/mL) concentration of Bupivacaine Hydrochloride Injection is not recommended for obstetrical anesthesia and should be reserved for surgical procedures where a high degree of muscle relaxation and prolonged effect are necessary ( 5.1 ).
Common side effects
- Anaesthetic complication
- Maternal exposure during delivery
- Local anaesthetic systemic toxicity
- Chondrolysis
- Exposure during pregnancy
- Hypotension
- Cauda equina syndrome
- Bradycardia
- Premature baby
- Foetal exposure during delivery
- Drug withdrawal syndrome
- Incorrect route of product administration
Drug interactions
- propranolol
Key clinical trials
- Effect of Scalp Block on Intraoperative Hemodynamics and Postoperative Pain in Craniotomy Patients" (NA)
- Repeated Bilateral Greater Occipital Nerve Blockade in Chronic Migraine and Chronic Tension-Type Headache (NA)
- Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block for Analgesia in Arthroscopic Shoulder Surgery (NA)
- Arthrosemid vs. Steroid for the Management Knee Osteoarthritis (PHASE4)
- Bilateral Cervical Plexus Block for Postoperative Pain After Thyroidectomy (NA)
- Regional Nerve Blocks to Improve Analgesia and Recovery in Older Adults Undergoing Spinal Fusion (EARLY_PHASE1)
- mTLIP vs QIPB for Postoperative Analgesia in Lumbar Microdiscectomy Surgery (NA)
- Continuous Epidural With Dexmedetomidine Adjuvant in Gynecologic Laparotomy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bupivacaine Hydrochloride And Epinephrine CI brief — competitive landscape report
- Bupivacaine Hydrochloride And Epinephrine updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Bupivacaine Hydrochloride And Epinephrine
What is Bupivacaine Hydrochloride And Epinephrine?
How does Bupivacaine Hydrochloride And Epinephrine work?
What is Bupivacaine Hydrochloride And Epinephrine used for?
Who makes Bupivacaine Hydrochloride And Epinephrine?
What is the generic name of Bupivacaine Hydrochloride And Epinephrine?
What drug class is Bupivacaine Hydrochloride And Epinephrine in?
When was Bupivacaine Hydrochloride And Epinephrine approved?
What development phase is Bupivacaine Hydrochloride And Epinephrine in?
What are the side effects of Bupivacaine Hydrochloride And Epinephrine?
What does Bupivacaine Hydrochloride And Epinephrine target?
Related
- Drug class: All Amide Local Anesthetic drugs
- Target: All drugs targeting Cytochrome P450 2D6
- Manufacturer: Pfizer — full pipeline
- Indication: Drugs for Anesthesia for cesarean section
- Indication: Drugs for Itching of skin
- Indication: Drugs for Local Anesthesia for Ophthalmologic Procedure
- Compare: Bupivacaine Hydrochloride And Epinephrine vs similar drugs
- Pricing: Bupivacaine Hydrochloride And Epinephrine cost, discount & access